These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34481143)

  • 1. Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases.
    Feng X; Luo D; Wei G; Zhan F; Hua F; Xu G
    Int Immunopharmacol; 2021 Nov; 100():108105. PubMed ID: 34481143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous nanoparticles and endogenous crystalline molecules as danger signals for the NLRP3 inflammasomes.
    Shirasuna K; Karasawa T; Takahashi M
    J Cell Physiol; 2019 May; 234(5):5436-5450. PubMed ID: 30370619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as important regulators of the NLRP3 inflammasome.
    Zamani P; Oskuee RK; Atkin SL; Navashenaq JG; Sahebkar A
    Prog Biophys Mol Biol; 2020 Jan; 150():50-61. PubMed ID: 31100298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of NLRP3 by non-coding RNAs in different cancers: interplay between non-coding RNAs and NLRP3 in carcinogenesis and metastasis.
    Farooqi AA; Attar R; Tanriover G; Sabitaliyevich UY; Zhailganov A; Rabandiyarov M
    Cell Mol Biol (Noisy-le-grand); 2020 Dec; 66(8):47-51. PubMed ID: 34174977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional crosstalk between Long non-coding RNAs and the NLRP3 inflammasome in the regulation of diseases.
    Luo D; Liu F; Zhang J; Shao Q; Tao W; Xiao R; Dai W; Qian K
    Mol Immunol; 2021 Mar; 131():191-200. PubMed ID: 33446392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanistic view of non-coding RNAs as a regulator of inflammatory pathogenesis of Parkinson's disease.
    Li Y; Yu C; Jiang X; Fu J; Sun N; Zhang D
    Pathol Res Pract; 2024 Jun; 258():155349. PubMed ID: 38772115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucoxanthin from microalgae Phaeodactylum tricornutum inhibits pro-inflammatory cytokines by regulating both NF-κB and NLRP3 inflammasome activation.
    Lee AH; Shin HY; Park JH; Koo SY; Kim SM; Yang SH
    Sci Rep; 2021 Jan; 11(1):543. PubMed ID: 33436909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NLRP3 inflammasome pathway in atherosclerosis: Focusing on the therapeutic potential of non-coding RNAs.
    Al-Hawary SIS; Jasim SA; Romero-Parra RM; Bustani GS; Hjazi A; Alghamdi MI; Kareem AK; Alwaily ER; Zabibah RS; Gupta J; Mahmoudi R; Hosseini-Fard S
    Pathol Res Pract; 2023 Jun; 246():154490. PubMed ID: 37141699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of NLRP3 inflammasome in inflammatory bowel diseases.
    Tourkochristou E; Aggeletopoulou I; Konstantakis C; Triantos C
    World J Gastroenterol; 2019 Sep; 25(33):4796-4804. PubMed ID: 31543674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases.
    Özenver N; Efferth T
    Pharmacol Res; 2021 Aug; 170():105710. PubMed ID: 34089866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
    Takahashi M
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulatory mechanisms of NLRP3: Potential roles in inflammasome activation.
    Ge Q; Chen X; Zhao Y; Mu H; Zhang J
    Life Sci; 2021 Feb; 267():118918. PubMed ID: 33352170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRP3 Inflammasome in Acute Myocardial Infarction.
    Mauro AG; Bonaventura A; Mezzaroma E; Quader M; Toldo S
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):175-187. PubMed ID: 31356555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP3 inflammasome in ischemic stroke: As possible therapeutic target.
    Alishahi M; Farzaneh M; Ghaedrahmati F; Nejabatdoust A; Sarkaki A; Khoshnam SE
    Int J Stroke; 2019 Aug; 14(6):574-591. PubMed ID: 30940045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NLRP3 inflammasome as a key driver of vascular disease.
    Takahashi M
    Cardiovasc Res; 2022 Jan; 118(2):372-385. PubMed ID: 33483732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorofenidone attenuates interleukin-1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction.
    Zheng L; Zhang J; Yuan X; Tang J; Qiu S; Peng Z; Yuan Q; Xie Y; Mei W; Tang Y; Meng J; Hu G; Tao L
    Nephrology (Carlton); 2018 Jun; 23(6):573-584. PubMed ID: 28437591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Long Non-coding RNAs: Paramount Regulators of the NLRP3 Inflammasome.
    Menon MP; Hua KF
    Front Immunol; 2020; 11():569524. PubMed ID: 33101288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
    Lee S; Suh GY; Ryter SW; Choi AM
    Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enigmatic inflammasomes.
    Triantafilou K
    Immunology; 2021 Mar; 162(3):249-251. PubMed ID: 33590488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.